Literature DB >> 6334107

A new headholder for PET, CT, and NMR imaging.

K J Kearfott, D A Rottenberg, R J Knowles.   

Abstract

A new headholder was developed for patient restraint and repositioning during positron emission tomography (PET), CT, and nuclear magnetic resonance (NMR) imaging procedures. A customized form was produced for each patient by pouring polyurethane resin and catalyst between an injection-molded polystyrene shell and a protective latex sheet and placing the patient's head in the form while the resin set. Excellent head restraint and repositioning was achieved when the headholder was used with a crossed-laser system. Repositioning accuracy was demonstrated by comparing transmission scans of the same patient obtained on different days and by comparing PET transmission scans with coplanar CT scans. No artifacts due to the headholder were apparent in CT, PET, and NMR images.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334107     DOI: 10.1097/00004728-198412000-00042

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  3 in total

1.  Quantification of fMRI artifact reduction by a novel plaster cast head holder.

Authors:  V Edward; C Windischberger; R Cunnington; M Erdler; R Lanzenberger; D Mayer; W Endl; R Beisteiner
Journal:  Hum Brain Mapp       Date:  2000-11       Impact factor: 5.038

2.  Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.

Authors:  S L Dewey; G S Smith; J Logan; J D Brodie; P Simkowitz; R R MacGregor; J S Fowler; N D Volkow; A P Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

3.  Applying independent component analysis to clinical FMRI at 7 t.

Authors:  Simon Daniel Robinson; Veronika Schöpf; Pedro Cardoso; Alexander Geissler; Florian Ph S Fischmeister; Moritz Wurnig; Siegfried Trattnig; Roland Beisteiner
Journal:  Front Hum Neurosci       Date:  2013-09-02       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.